Home › Funds › LexAurum Advisors, LLC › PGEN

LexAurum Advisors, LLC position in PGEN

PRECIGEN INC · Health Care

LexAurum Advisors, LLC reported holding 633,533 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 0.61% of its reported portfolio and ranking #38 among its reported holdings. LexAurum Advisors, LLC has disclosed PGEN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)633.53K sh
Reported value held$5.42M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-10-19

Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR

How LexAurum Advisors, LLC's PGEN position evolved

LexAurum Advisors, LLC first disclosed a stake in PGEN in Q3 2023 at 92,666 shares (US$132K). The position peaked in Q3 2026 at 633,533 shares, worth US$5.4M. Across 11 filings, LexAurum Advisors, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 633,533 shares valued at US$5.4M — a reduction of -4,880 shares quarter over quarter.. Notable position changes include a 208% increase in Q3 2024 (shares rose 18% over the following quarter), a 152% increase in Q4 2024 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 92.67K $131.59K New
Q4 2023 97.77K $131.01K Add
Q1 2024 89.17K $129.29K Reduce
Q3 2024 274.49K $259.97K Add
Q4 2024 691.54K $774.53K Add
Q1 2025 685.30K $1.02M Reduce
Q2 2025 672.54K $955.01K Reduce
Q3 2025 666.04K $2.19M Reduce
Q1 2026 689.41K $2.67M Add
Q2 2026 638.41K $3.64M Reduce
Q3 2026 633.53K $5.42M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PGEN and 13F data

PGEN (PRECIGEN INC) is a Health Care company. 58 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PGEN

All PGEN fund holders →

FAQ

How long has LexAurum Advisors, LLC held PGEN?

LexAurum Advisors, LLC has disclosed PGEN holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is LexAurum Advisors, LLC's current position in PGEN?

As of Q3 2026, LexAurum Advisors, LLC holds 633.53K shares of PGEN (PRECIGEN INC), valued at $5.42M, representing 0.61% of its reported portfolio and ranking #38.

Has LexAurum Advisors, LLC been buying or selling PGEN?

In the latest 13F filing (Q3 2026), LexAurum Advisors, LLC reduced its position in PGEN. The position peaked in Q3 2026 at 633.53K shares.

Which other funds hold PGEN?

Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.